02 October 2021
The risk of serious COVID-19 is very low among partially and fully vaccinated people, but vaccinated men, older people and people with multiple underlying health conditions are still at risk, according to a nationwide study in Scotland.
01 October 2021
Research funded by the NIHR has found that it is safe for people to receive a flu vaccine at the same time as a COVID-19 vaccine.
30 September 2021
New research supported by the NIHR has shown that 37% of people who experienced COVID-19 had at least one long COVID symptom in the 3-6 month period after infection.
20 September 2021
A tool developed by NIHR-funded researchers has been shown to accurately identify people who are at greatest risk from severe COVID-19 despite being fully vaccinated.
17 September 2021
A COVID-19 vaccine study backed through funding from the Vaccines Taskforce and National Institute for Health Research (NIHR) has expanded to include people aged 12 to 16, as it looks to analyse different vaccination schedules in young people.
16 September 2021
Data drawn from a collection of National Institute for Health Research-supported COVID-19 vaccine studies has informed key decisions made for the UK’s booster programme.
02 September 2021
Up to one in seven children and young people who had COVID-19 may have symptoms linked to the virus 15 weeks later, suggest preliminary findings from the world’s largest study on long COVID in children.
03 August 2021
New government-funded clinical study investigating best COVID-19 vaccine dose interval for pregnant women launches.
18 July 2021
People experiencing long COVID will benefit from a comprehensive package of new NIHR-funded research to help improve the understanding of the condition, from diagnosis and treatment through to rehabilitation and recovery.
16 July 2021
People who experience five or more symptoms of COVID-19 in the first week of infection are more likely to develop long-term health problems, irrespective of age or gender, according to a new review of research on long COVID.
29 June 2021
The first participants in the world have been vaccinated using a Oxford/AstraZeneca variant vaccine, aimed at preventing the Beta COVID-19 variant.
28 June 2021
Alternating doses of the Oxford/AstraZeneca and Pfizer vaccines generate robust immune responses against COVID-19, an NIHR supported study has found. The Com-COV study is led by the University of Oxford and run across eight NIHR sites in the UK.
24 June 2021
Up to one in three people who report being infected by SARS-CoV-2 also report long COVID symptoms, with older people and women more likely to be affected.
18 June 2021
Researchers, study participants and members of the public are today recognising the efforts of all of those involved in COVID-19 research, by supporting the #Red4Research campaign.
14 June 2021
Many common dental procedures have a very low risk of increasing the aerosol spread of COVID-19, suggests new research funded by NIHR and UKRI.
03 June 2021
Volunteers in a world-first COVID-19 vaccine booster study have received their first booster jabs in Bradford, as part of the National Institute for Health Research-supported Cov-Boost study. Over 2,800 participants are being recruited to help to provide vital data on the impact of a third dose on patients’ immune responses.
02 June 2021
Over 500,000 people have now signed up to be contacted about hearing how to be involved in COVID-19 vaccine studies. Health and Social Care Secretary Matt Hancock MP announced the milestone at the Downing Street Press Conference on 27 May.
20 May 2021
Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching today, Health Secretary Matt Hancock has announced. The Cov-Boost study, backed by £19.3 million of government funding through the Vaccines Taskforce, will be run at 16 National Institute for Health Research sites.
17 May 2021
The first COVID-19 vaccine study in the UK recruiting pregnant women has been launched across several National Institute of Health Research sites. The phase 2/3 study aims to further understand the safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in healthy pregnant women.
26 April 2021
4,000 volunteers are set to be recruited to the latest vaccine study running in the UK, examining a new COVID-19 vaccine candidate. Developed by specialty vaccine company Valneva, the vaccine is being manufactured at the company’s site in Livingston, West Lothian.
26 April 2021
A single dose of either the Oxford-AstraZeneca or Pfizer-BioNTech vaccines leads to a substantial drop in the spread of COVID-19, new research supported by the NIHR has shown.
12 April 2021
Treatment with the inhaled asthma drug budesonide reduces recovery time in patients with COVID-19 who are treated at home and in other community settings, new results from research funded and supported by the NIHR have shown.
08 April 2021
The antiviral drug favipiravir will be investigated as a treatment for COVID-19 in people recovering at home and in other non-hospital settings, in a clinical trial funded and supported by the NIHR.
25 March 2021
The NIHR has launched a second call for research proposals on helping and supporting people with Long COVID.
25 March 2021
A new NIHR funded study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
